title: Transplant-acquired food allergy (TAFA) following cord blood stem cell transplantation in two adult patients with haematological malignancies.
authors: Haematology Department, King's College Hospital, London, UK; Department of Haematological Medicine, King's College London, Rayne Institute, London, UK. jfeliusa@yahoo.es.
authors: Jesus
authors: J
authors: Feliu
authors: Jennifer
authors: J
authors: Clay
authors: Kavita
authors: K
authors: Raj
authors: Linda
authors: L
authors: Barber
authors: Vikesh
authors: V
authors: Devlia
authors: Bronwen
authors: B
authors: Shaw
authors: Antonio
authors: A
authors: Pagliuca
authors: Ghulam
authors: G
authors: Mufti
mesh_terms: D000328:Adult; D000677:Amsacrine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D036101:Cord Blood Stem Cell Transplantation / Q000009:adverse effects*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D021181:Egg Hypersensitivity / Q000209:etiology; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D005512:Food Hypersensitivity / Q000209:etiology* / Q000276:immunology; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007410:Intestinal Diseases / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000628:therapy*; D008107:Liver Diseases / Q000188:drug therapy / Q000209:etiology / Q000276:immunology; D008297:Male; D008875:Middle Aged; D021184:Nut Hypersensitivity / Q000209:etiology; D017747:Seafood / Q000009:adverse effects; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use; D019172:Transplantation Conditioning; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D007166:Immunosuppressive Agents; D000677:Amsacrine; D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D005047:Etoposide; D014740:Vidarabine; D016559:Tacrolimus; D015255:Idarubicin; D003630:Daunorubicin
keywords: cord blood stem cell transplantation; graft-versus-host disease; haemopoietic stem cell transplantation; tacrolimus; transplant-acquired food allergy